XML 35 R17.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stock Compensation Plans | 12 Months Ended
--- | ---
Dec. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Compensation Plans | 9. Stock Compensation Plans Accounting for Stock-Based Compensation The various Company stock compensation plans are summarized below. For all stock compensation plans, the company’s policy is to issue treasury shares for option/stock appreciation right (SAR) exercises, restricted stock unit (RSU) releases and employee stock purchase plan (ESPP) purchases. 2011 Non-employee Directors’ Equity Incentive Plan In June 2011, the stockholders adopted an equity incentive plan for non-employee directors (the “2011 Directors Plan”) providing for grants of stock options, SARs, RSUs and/or performance shares, pursuant to which up to 122,592 shares were available for issuance. The term of each award cannot exceed ten years. Awards may vest over a minimum two-year period. In 2017, 2016, and 2015, 10,432, 12,984, and 12,008 RSUs were granted under this plan. 2005 Equity Incentive Plan In June 2005, the shareholders adopted an equity incentive plan (the “2005 Plan”) providing for grants of incentive and nonqualified stock options, SARs, RSUs and/or performance shares to employees of the Company and its subsidiaries, pursuant to which up to 10,000,000 common shares were available for issuance. In 2013, the shareholders approved an additional 3,000,000 shares to the plan, making the total shares authorized under the plan 13,000,000. Option and SAR grants vest evenly over a period of five years or as otherwise determined by the Board of Directors or the Compensation Committee and generally expire ten years from the date of grant, if not exercised. RSUs granted prior to December 10, 2012 vested evenly over a period of five years, while RSUs granted on and after that date vested or are vesting evenly over a period of three years. In addition to time-based vesting requirements, the vesting of certain RSU grants is also contingent upon the Company’s achievement of certain financial performance goals. During 2017, 2016, and 2015, 1,044,045, 1,228,427, and 1,171,905 RSUs were granted under the 2005 Plan. No SARs were granted under the 2005 Plan in 2017, 2016, and 2015. 2000 Equity Incentive Plan In October 2000, the shareholders adopted an equity incentive plan (the “2000 Plan”) providing for grants of incentive and nonqualified stock options, SARs, RSUs and/or performance shares to employees of the Company and its subsidiaries, pursuant to which up to 7,000,000 common shares were available for issuance. The stock options and SARs vest evenly over a period of five years or as otherwise determined by the Board of Directors or the Compensation Committee and generally expire ten years from the date of grant, if not exercised. The Company did not grant any stock awards from the 2000 Plan in 2017, 2016, or 2015. 2000 Non-employee Directors’ Option Plan Also in October 2000, the stockholders adopted a stock option plan for non-employee directors (the “2000 Directors Plan”) providing for grants of options for up to 100,000 common shares. In 2009, the stockholders approved an additional 150,000 shares to the plan, making the total shares authorized under the plan 250,000. The term of each award is ten years. All awards vest evenly over a three-year period. Following the June 2011 approval of the 2011 Directors Plan, the Company will no longer issue options to purchase shares under this plan. Stock-Based Compensation Activity A summary of the Company’s stock-based compensation activity and related information under the 2011 Directors Plan, the 2005 Plan, the 2000 Plan and the 2000 Directors Plan for the years ended December 30, 2017, December 31, 2016, and December 26, 2015 is provided below:
|  | Stock Options and SARs |
|  | Weighted-Average |  |  |  |
|  | Exercise Price |  |  | Number of Shares |
|  |  |  |  | (In Thousands) |
Outstanding at December 27, 2014 |  | $ | 63.19 |  |  |  | 4,731 |
Granted |  |  |  |  |  |  | - |
Exercised |  | $ | 29.15 |  |  |  | (474 | )
Forfeited/Expired |  | $ | 70.58 |  |  |  | (196 | )
Outstanding at December 26, 2015 |  | $ | 66.80 |  |  |  | 4,061 |
Granted |  |  |  |  |  |  | - |
Exercised |  | $ | 50.77 |  |  |  | (716 | )
Forfeited/Expired |  | $ | 51.12 |  |  |  | (608 | )
Outstanding at December 31, 2016 |  | $ | 74.48 |  |  |  | 2,737 |
Granted |  |  |  |  |  |  | - |
Exercised |  | $ | 50.15 |  |  |  | (397 | )
Forfeited/Expired |  | $ | 84.57 |  |  |  | (1,948 | )
Outstanding at December 30, 2017 |  | $ | 48.94 |  |  |  | 392 |
Exercisable at December 30, 2017 |  | $ | 48.76 |  |  |  | 365 |
Expected to vest after December 30, 2017 |  | $ | 51.46 |  |  |  | 27 |
Stock Options and SARs as of December 30, 2017
Exercise |  | Awards |  |  | Remaining |  |  | Awards |
Price |  | Outstanding |  |  | Life (Years) |  |  | Exercisable |
|  | (In Thousands) |  |  |  |  |  | (In Thousands) |
$18.00 - $40.00 |  |  | 21 |  |  |  | 1.98 |  |  |  | 21 |
$40.01 - $60.00 |  |  | 369 |  |  |  | 2.39 |  |  |  | 343 |
$60.01 - $80.00 |  |  | - |  |  |  | - |  |  |  | - |
$80.01 - $100.00 |  |  | 2 |  |  |  | 0.01 |  |  |  | 2 |
$100.01 - $120.00 |  |  | - |  |  |  | - |  |  |  | - |
$120.01 - $140.00 |  |  | - |  |  |  | - |  |  |  | - |
|  |  | 392 |  |  |  | 2.36 |  |  |  | 366 |
|  | Restricted Stock Units |
|  | Weighted-Average |  |  |  |
|  | Grant Date Fair Value |  |  | Number of Shares |
|  |  |  |  | (In Thousands) |
Outstanding at December 27, 2014 |  | $ | 42.55 |  |  |  | 1,088 |
Granted |  | $ | 37.07 |  |  |  | 1,184 |
Released/Vested |  | $ | 40.18 |  |  |  | (562 | )
Cancelled |  | $ | 42.02 |  |  |  | (53 | )
Outstanding at December 26, 2015 |  | $ | 39.45 |  |  |  | 1,657 |
Granted |  | $ | 40.59 |  |  |  | 1,241 |
Released/Vested |  | $ | 38.96 |  |  |  | (565 | )
Cancelled |  | $ | 44.57 |  |  |  | (509 | )
Outstanding at December 31, 2016 |  | $ | 38.94 |  |  |  | 1,824 |
Granted |  | $ | 51.71 |  |  |  | 1,055 |
Released/Vested |  | $ | 39.31 |  |  |  | (763 | )
Cancelled |  | $ | 40.40 |  |  |  | (54 | )
Outstanding at December 30, 2017 |  | $ | 45.30 |  |  |  | 2,062 |
The weighted-average remaining contract life for stock options and SARs outstanding and exercisable at December 30, 2017 was 2.36 and 2.05 years, respectively. The weighted-average remaining contract life of restricted stock units at December 30, 2017 was 1.29 years. The total fair value of awards vested during 2017, 2016, and 2015 was $30,280, $22,429, and $23,351, respectively. The aggregate intrinsic values of options and SARs outstanding and exercisable at December 30, 2017 were $4,209 and $3,994, respectively. The aggregate intrinsic values of options and SARs exercised during 2017, 2016, and 2015 were $3,742, $1,632, and $3,714, respectively. The aggregate intrinsic value of RSUs outstanding at December 30, 2017 was $122,885. The aggregate intrinsic values of RSUs released during 2017, 2016, and 2015 were $45,424, $27,386, and $20,787, respectively. Aggregate intrinsic value of options and SARs represents the applicable number of awards multiplied by the positive difference between the exercise price and the Company’s closing stock price on the last trading day of the relevant fiscal period. Aggregate intrinsic value of RSUs represents the applicable number of awards multiplied by the Company’s closing stock price on the last trading day of the relevant fiscal period. The Company’s closing stock price was $59.57 on December 30, 2017. As of December 30, 2017, there was $65,166 of total unrecognized compensation cost related to unvested share-based compensation awards granted to employees under the stock compensation plans. That cost is expected to be recognized over the weighted average remaining vesting period. Employee Stock Purchase Plan The shareholders have adopted an ESPP. Up to 6,000,000 shares of common stock have been reserved for the ESPP, including 2,000,000 shares approved by shareholders in June 2015. Shares will be offered to employees at a price equal to the lesser of 85% of the fair market value of the stock on the date of purchase or 85% of the fair market value on the first day of the ESPP period. The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. During 2017, 2016, and 2015, 489,267, 541,018, 488,753 shares, respectively, were purchased under the plan for a total purchase price of $20,996, $18,157, and $16,789, respectively. During 2017, 2016, and 2015, the purchases were issued from treasury shares. At December 30, 2017, approximately 970,366 shares were available for future issuance.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration